USP35 and colorectal carcinoma: Resultantly, enhanced USP35 expression increased FUCA1 at protein levels in CRC cells and HEK293T in a dose dependent manner (Fig. S6A, B), while dampened USP35 expression clearly decreased the protein levels of FUCA1 in DLD-1 and HCT116 cells (Fig. S6C).